These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29860331)

  • 21. Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study.
    Higgins CR; Kobia B; Ozawa S
    PLoS One; 2023; 18(1):e0268661. PubMed ID: 36652447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Legal Uncertainty-The Gray Area around Substandard Medicines: Where Public Health Meets Law.
    Olliaro E; Olliaro P; Ho CWL; Ravinetto R
    Am J Trop Med Hyg; 2020 Feb; 102(2):262-267. PubMed ID: 31746313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of combined screening methods for rapid detection of falsified and/or substandard medicines in the absence of a confirmatory method.
    Opuni KF; Nettey H; Larbi MA; Amartey SNA; Nti G; Dzidonu A; Owusu-Danso P; Owusu NA; Nyarko AK
    Malar J; 2019 Dec; 18(1):403. PubMed ID: 31805937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community.
    Kniazkov S; Dube-Mwedzi S; Nikiema JB
    J Pharm Policy Pract; 2020; 13():71. PubMed ID: 33088577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substandard and Falsified Medications: A Barrier to Global Health Equity Exemplified in Ecuador.
    Yakhkind A; Lang AE; Brophy G; Tesoro E; Levasseur-Franklin KE; Maldonado N
    Neurocrit Care; 2023 Feb; 38(1):1-6. PubMed ID: 36517662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low Prevalence of Substandard and Falsified Antimalarial and Antibiotic Medicines in Public and Faith-Based Health Facilities of Southern Malawi.
    Khuluza F; Kigera S; Heide L
    Am J Trop Med Hyg; 2017 May; 96(5):1124-1135. PubMed ID: 28219993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community pharmacists' knowledge of substandard and falsified medicines in clinical practice: a cross-sectional survey in Saudi Arabia.
    Bashayr Ali A; Barrett R
    Int J Pharm Pract; 2023 Apr; 31(2):176-182. PubMed ID: 36748987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facing suspected child abuse--what keeps Swedish general practitioners from reporting to child protective services?
    Talsma M; Bengtsson Boström K; Östberg AL
    Scand J Prim Health Care; 2015 Mar; 33(1):21-6. PubMed ID: 25676563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the Health and Economic Impact of Substandard and Falsified Medicines: A Review of Existing Models and Approaches.
    Ozawa S; Higgins CR; Nwokike JI; Phanouvong S
    Am J Trop Med Hyg; 2022 Jul; 107(1):14-20. PubMed ID: 35895357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poor-quality antimalarials further health inequities in Uganda.
    Evans DR; Higgins CR; Laing SK; Awor P; Ozawa S
    Health Policy Plan; 2019 Dec; 34(Supplement_3):iii36-iii47. PubMed ID: 31816072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the problem of counterfeit medications in the United Kingdom.
    Jackson G; Patel S; Khan S
    Int J Clin Pract; 2012 Mar; 66(3):241-50. PubMed ID: 22070229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The quality of veterinary medicines and their implications for One Health.
    Vidhamaly V; Bellingham K; Newton PN; Caillet C
    BMJ Glob Health; 2022 Aug; 7(8):. PubMed ID: 35918072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The era of fake medicines: Investigating counterfeit medicinal products for erectile dysfunction disguised asherbal supplements.
    Ho HMK; Xiong Z; Wong HY; Buanz A
    Int J Pharm; 2022 Apr; 617():121592. PubMed ID: 35182703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Falsification of biotechnology drugs: current dangers and/or future disasters?
    Janvier S; De Spiegeleer B; Vanhee C; Deconinck E
    J Pharm Biomed Anal; 2018 Nov; 161():175-191. PubMed ID: 30165334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When falsified medicines enter the supply chain: description of an incident in Kenya and lessons learned for rapid response.
    Cohn J; von Schoen-Angerer T; Jambert E; Arreghini G; Childs M
    J Public Health Policy; 2013 Jan; 34(1):22-30. PubMed ID: 23172047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating Low-Cost Optical Spectrometers for the Detection of Simulated Substandard and Falsified Medicines.
    Wang W; Keller MD; Baughman T; Wilson BK
    Appl Spectrosc; 2020 Mar; 74(3):323-333. PubMed ID: 31617368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Falsified vardenafil tablets available online.
    Zhu S; Yoshida N; Kimura K; Matsushita R; Tsuboi H
    J Pharm Biomed Anal; 2020 Jan; 177():112872. PubMed ID: 31525574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance for substandard and falsified medicines by local faith-based organizations in 13 low- and middle-income countries using the GPHF Minilab.
    Gnegel G; Häfele-Abah C; Neci R; ; Heide L
    Sci Rep; 2022 Jul; 12(1):13095. PubMed ID: 35908047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries.
    Rasheed H; Höllein L; Holzgrabe U
    Front Pharmacol; 2018; 9():995. PubMed ID: 30233373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of impurities and dissolution profiles of illegal antimicrobial drugs encountered in Belgium.
    Tie Y; van Loock K; Deconinck E; Adams E
    Drug Test Anal; 2020 Jan; 12(1):53-66. PubMed ID: 31454468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.